Previous studies have established that genetic modifications involving the cardiac *α-*subunit, *SCN5A*, can result in arrhythmic cardiac conditions. These include not only ventricular conditions such as the Brugada (BrS) ([@b31]) and long QT syndromes (LQTS) ([@b33]), but also atrial conditions, such as atrial fibrillation (AF) ([@b29], [@b30], [@b8]). However, there are only a limited number of reports that have considered the possible associations of *β*-subunits with such human arrhythmic conditions. The mRNA encoding for these *β-*subunits are all expressed in human, skeletal and cardiac tissue ([@b23], [@b17], [@b28], [@b32], [@b37], [@b5]). They have a number of possible functions. Firstly, they may regulate the membrane expression density of the Na^+^ channels themselves ([@b17], [@b7]). Secondly, the *β*-subunits contain extracellular immunoglobulin (Ig) loop domains that may have functions similar to those of cell adhesion molecules (CAMs) ([@b14]). Finally, these subunits may also modulate gating properties of the Na^+^ channel ([@b15], [@b16], [@b28], [@b7], [@b18], [@b11]).

Recent clinical studies have associated mutations in the genes encoding for *β*-subunits with cardiac arrhythmogenesis. One mutation involving the gene encoding for the *β*~4~ subunit (*SCN4B*) has been associated with LQT3 ([@b26]). Three mutations involving the gene encoding for the *β*~1~ subunit (*SCN1B*) and one mutation in the gene encoding for the *β*~3~ subunit (*SCN3B*) have been associated with BrS ([@b34], [@b13]). Similarly, there have been relatively few studies in murine models containing *β*-subunit mutations examining cardiac arrhythmogenesis. Electrocardiograms (ECGs) from mice lacking the *Scn1b* gene showed longer RR intervals and prolonged QT intervals compared to those shown in WT hearts ([@b20]). Additionally, ventricular tachycardia induced by programmed electrical stimulation was demonstrated in Langendorff-perfused hearts isolated from *Scn3b*^−/−^ mice ([@b11]).

The present study adds to the latter investigation, which was confined to examining ventricular electrophysiology. It goes on to associate the deletion of the *Scn3b* gene with abnormal atrial electrophysiology, as well as atrial-ventricular (A-V) block, conduction abnormalities and atrial arrhythmias. The following properties were compared in the hearts of WT and *Scn3b*^*−/−*^ mice. Firstly, mRNA expression levels of *Scn3b*, *Scn1b* and *Scn5a* were explored in atrial tissue. Secondly, expression of *β*~3~ proteins was investigated in isolated cardiac myocytes using immunofluorescence methods. Thirdly, ECGs were investigated in intact anaesthetized mice. Finally, electrophysiological properties of isolated Langendorff-perfused hearts were assessed using bipolar electrogram (BEG) recordings. The latter were obtained from the atrial appendages of spontaneously beating and electrically stimulated hearts. Arrhythmogenicity and sinus node function was also investigated using atrial burst pacing (ABP) and sinus node recovery time (SNRT) protocols respectively.

Materials and methods
=====================

Experimental animals
--------------------

The genetically modified mice used were first described by [@b11]. The 129sv mice were kept in cages at a room temperature of 21 ± 1 °C in an animal facility with 12 h light/dark cycles. The mice had free access to sterilized rodent chow and water. All male and female offspring of the wild-type (WT) and *Scn3b*^*−/−*^ mice (age 5--8 months) were randomly selected in all experiments and were killed by cervical dislocation in all real-time polymerase chain reaction and *ex vivo* experiments \[Schedule 1: UK Animals (Scientific Procedures) Act 1986\].

Analysis of Na^+^ channel *α-* and *β-*subunit transcripts
----------------------------------------------------------

Analysis of mRNA expression levels of sodium channel *α-* and *β*-subunits was performed as described in a previous paper ([@b11]), except that mRNA was isolated from atrial appendages (*n* = 3).

Cardiac myocyte isolation and immunolocalization of Scn3b subunits
------------------------------------------------------------------

A basic isolation buffer consisting of (in m[m]{.smallcaps}): 120 NaCl, 5.4 KCl, 5 MgSO~4~, 5.5 sodium pyruvate, 10 glucose, 20 taurine and 10 HEPES was used to make the following solutions. Firstly, a nitrilotriacetic acid (NTA) buffer consisted of the basic isolation buffer with 5 m[m]{.smallcaps} NTA and adjusted to pH 6.95. Secondly, a digestion buffer consisted of the basic isolation buffer to which 0.25 m[m]{.smallcaps} CaCl~2~, 1 mg mL^−1^ collagenase type 2 (Worthington, Lakewood, NJ, USA) and 1 mg mL^−1^ hyaluronidase (Sigma-Aldrich, Poole, UK) was added. Thirdly, a stop buffer consisted of the basic isolation buffer and containing 2 mg mL^−1^ bovine serum albumin (Sigma-Aldrich). Fourthly, a wash buffer consisted of the basic isolation buffer to which 0.6 m[m]{.smallcaps} CaCl~2~ was added. Finally, a storage buffer was similar to the wash buffer but contained 1.2 m[m]{.smallcaps} CaCl~2~. All the buffers created, except for the NTA buffer, had their pH adjusted to 7.4.

Hearts from adult mice were rapidly excised and submerged in ice-cold isolation buffer. The hearts were then retrogradely perfused for 2 min with NTA buffer using a variable speed peristaltic pump at a flow rate of 3.5 mL min^−1^(model EV045; Autoclude Peristaltic Pumps, Essex, UK). Before perfusion, the buffer was warmed to 37 °C with a water jacket and circulator (Techne model RB-5 A; Bibby Scientific Limited, Staffordshire, UK). Immediately following this, the NTA buffer was replaced with the digestion buffer and perfused in the same fashion for 12--15 min. Using watchmaker's forceps, tissue was taken from the whole heart and placed in the stop buffer. After transferring into a 15 mL test tube, single myocytes were isolated from the harvested cardiac tissue through gentle trituration. After allowing 5 min for the cells to settle, the supernatant was then gently removed and the cells were washed using the wash buffer. Following a further 5 min, the isolated myocytes were resuspended and stored in the storage buffer. After each step following the harvesting of the cells, isolated myocytes were checked under a light microscope. Live myocytes appeared as smooth and rod-shaped cells.

Glass coverslips individually placed in the wells of a 24-well tissue culture plate were first coated with 0.1 mg mL^−1^ polylysine (Sigma-Aldrich) for 15 min at room temperature and air dried overnight. Isolated myocytes were attached to the coverslips by a brief centrifugation (900 rpm/115 ***g*** for 2--3 min). After the supernatant was carefully aspirated, cells were fixed by incubation in 1 mL 4% paraformaldehyde/phosphate-buffered saline (PBS) for 12 min at room temperature. Following this, the paraformaldehyde was removed from each well and replaced with 1 mL permeabilizing/blocking buffer solution, which contained 0.1% Triton X100, 0.02% saponin and 10% fetal calf serum in PBS. After 1 h incubation at room temperature, the solution was carefully removed. The myocytes were then incubated overnight at 4 °C in an affinity-purified rabbit anti-*β*~3~ antibody, diluted in the permeabilizing/blocking solution at a dilution of 1/50. This antibody was raised against the RPEGGKDFLIYE peptide ([@b10]). After aspirating the primary antibody solution, the myocytes were rinsed with a wash buffer, which contained 0.1% Triton X100 and 0.02% saponin in PBS. Following four such washes, the myocytes were incubated for 1 h at room temperature with an Alexa Fluor-labelled goat anti-rabbit antibody (Invitrogen, Paisley, UK), diluted in permeabilizing/blocking solution at a dilution of 1/1000. After a further five washes as described above, followed by a brief wash in distilled water, the coverslips were removed from the wells and air dried away from sunlight. They were then mounted on glass microscope slides using Vectastain hard mounting media (Vector Laboratories, Peterborough, UK). The myocytes were then analysed using a ×63 water-immersion objective lens and a Leica 6000 CS inverted microscope (Leica, Heidelberg, Germany). Alexa-Fluor was excited using a 488 nm argon laser and emission was collected between 500 and 580 nm. Images were obtained and analysed using the Leica AF software.

Surface ECG recordings in WT and Scn3b^*−/−*^ mice
--------------------------------------------------

ECG recordings were recorded from randomly selected male and female mice (age 6 months). Prior to examination, each mouse was anaesthetized using an intraperitoneal injection of ketamine/xylazine (150 and 5 mg/kg respectively). Fifteen minutes after administration of the anaesthetic, the mice were placed on a custom-made heat block to maintain body temperature during data acquisition. Lead I ECGs were obtained using subcutaneous 29-gauge needle electrodes (ADInstruments, Oxfordshire, UK), inserted in the left and right foreleg. These signals were pre-amplified using an NL100AK headstage and amplified with an NL104A amplifier (Neurolog, Hertfordshire, UK). The signals were then band-pass filtered between 40 Hz and 1 kHz using an NL125/6 filter (Neurolog) and digitized using an analog to digital converter (CED 1401plus MKII; Cambridge Electronic Design, Cambridge, UK). All digitized data were captured and analysed using Spike 2 software (Cambridge Electronic Design). The electrical signals were obtained at a sampling frequency of 5 kHz and acquired over a 5-min period. From each ECG recording, a 1-min period was analysed, to minimize variations between beats. The following parameters were investigated: P wave duration, RR interval, PR interval, QT~peak~ and QT intervals. The latter two intervals were measured from the onset of the QRS complex to the end and the peak of the T wave respectively. These intervals were expressed both uncorrected and corrected for heart rate (HR) using the modified Bazett's formula, QTc = QT/(RR/100)^1/2^, which allows for the high HR observed in mice ([@b27]).

Electrophysiological studies in isolated WT and Scn3b^*−/−*^ hearts
-------------------------------------------------------------------

The electrophysiological experiments were carried out in isolated Langendorff-perfused WT (*n* = 15) and *Scn3b*^−/−^ (*n* = 15) hearts, and were set up as described in a previous study ([@b11]). Each experiment typically lasted a period of up to 45 min to ensure that none of the electrophysiological recordings was the result of preparation deterioration. Following cannulation, all preparations were first permitted to assume their normal pattern of electrical activity over a period of 5 min. This was confirmed in BEG recordings obtained from the left atrial (LA) appendages. Atrial and ventricular contributions to such electrograms were distinguished by moving the position of the recording electrodes, from the centre to the lower extremity of the LA appendage, towards the ventricles. The ventricular contribution could then be clearly distinguished from the atrial contribution, through its relatively greater amplitude. The recording electrodes were then positioned in this lower region of the LA appendage throughout the remainder of each experiment.

Atrial BEG recordings
---------------------

In all experiments analysing the atria of the isolated, perfused murine heart, paired platinum stimulating electrodes (1 mm interpole spacing) were positioned over the epicardial surface of the right atrial (RA) appendage. Spontaneous atrial activity was examined by recording from the surface of the LA appendage using a silver chloride (2 mm tip diameter) recording electrode (Linton Instrumentation, Cambridgeshire, UK), which was manually positioned on the heart. The electrical signals obtained from these hearts provided BEG recordings. These signals were amplified and high-pass filtered for electrogram recordings (30 Hz to 1 kHz) using a Gould 2400S amplifier (Gould-Nicolet Technologies, Essex, UK) and then digitized using a digital converter (CED 1401plus MKII; Cambridge Electronic Design) at a sampling frequency of 5 kHz. All digitized data were then captured and analysed using Spike 2 software (Cambridge Electronic Design).

Atrial burst pacing and SNRT
----------------------------

Atrial electrophysiological activity was further assessed using established stimulation techniques ([@b3], [@b19]). The stimulating electrodes described above were connected to a Grass S48 stimulator (Grass-Telefactor, UK, Slough, UK), which delivered square-wave stimuli with a 2 ms duration at 1.5 to two times excitation threshold. The stimulation protocols were only applied to hearts first showing a regular spontaneous atrial rhythm. Inducibility of atrial arrhythmia and sinus dysfunction were assessed using ABP and SNRT protocols respectively. The ABP protocol imposed a drive train of 50 pulses at a cycle length (CL) of 20 ms and the resulting atrial activity observed immediately after the completion of the protocol. The SNRT protocol consisted of pacing the RA appendage for 15 s at a CL of 150 ms. The SNRT was measured as the duration between termination of the protocol and the return of spontaneous atrial activity.

Data analysis and statistical procedures
----------------------------------------

Data obtained from all experiments were first imported into Microsoft EXCEL. Single-factor analysis of variance for independent samples ([anova]{.smallcaps}) was used to compare data sets from WT and *Scn3b*^*−/−*^ (Microsoft EXCEL Analysis ToolPak). All results are shown as mean ± SEM values. Calculated values of *P* \< 0.05 were considered statistically significant.

Results
=======

mRNA and protein expression levels of Na^+^ channel subunits
------------------------------------------------------------

The real-time polymerase chain reaction (RT-PCR) was used to investigate mRNA expression levels of the Na^+^ channel subunits *Scn3b*, *Scn1b* and *Scn5a* in tissue from the RA and LA appendages of WT and *Scn3b*^−/−^ mice hearts. [Figure 1a](#fig01){ref-type="fig"} demonstrates that *Scn3b* mRNA was expressed at similar levels (black column) in LA and RA appendages of WT hearts (RA+/+ and LA+/+; *n* = 3, *P* \> 0.05). The ratio between the *β*~3~ and Na~v~1.5 mRNA expression levels in the LA and RA of WT murine hearts was 1 : 470 and 1 : 380, respectively, giving an overall ratio of 1 : 420 in the atrial appendages. In contrast, there was no detectable expression of *Scn3b* mRNA in the LA and RA appendages of the *Scn3b*^−/−^ hearts (RA−/− and LA−/−; *n* = 3, *P* \< 0.05). Both the LA and RA appendages showed similar and detectable expression levels of *Scn1b* ([Fig. 1b](#fig01){ref-type="fig"}) and *Scn5a* mRNA ([Fig. 1c](#fig01){ref-type="fig"}) in WT (black column) and *Scn3b*^−/−^ hearts (white column, *n* = 3 each; *P \>* 0.05). Furthermore, both WT and *Scn3b*^−/−^ hearts showed significantly higher expression levels of *Scn1b* and *Scn5a* mRNA in the LA than in the RA appendages (*n* = 3 each, *P* \< 0.05).

![Real-time polymerase chain reaction analysis of mRNA expression. The relative expression of mRNA (normalized and calculated as percentage of GAPDH expression) of encoding Na^+^ channel subunit transcripts. The histograms show data from the left and right atrial appendages (LA and RA respectively) of WT (black columns) and *Scn3b*^−/−^ (white columns) mice. (a) mRNA transcripts for *Scn3b* was shown in atrial appendages of WT (left: LA+/+; right: RA+/+; *n* = 3) and not detectable in atrial appendages of *Scn3b*^−/−^ mice (left: LA−/−; right: RA−/−; *n* = 3). The levels of *Scn1b* and *Scn5a* transcripts (panels b and c respectively) in the left and right atrial appendages of *Scn3b*^−/−^ hearts were similar to corresponding expression levels in the atrial appendages of WT hearts (*P* \> 0.05). Significance levels of *P* \< 0.05 (single factor [anova]{.smallcaps}) demonstrated differences between *Scn3b*^−/−^ (*n* = 3 hearts) and WT hearts (*n* = 3 hearts) and the left and right atrial appendages.](apha0198-0047-f1){#fig01}

Having confirmed the presence and absence of *Scn3b* mRNA expression in WT and *Scn3b*^−/−^ myocytes, respectively, the present study used immunofluorescence methods to assess the expression of the *β*~3~ subunits in cardiac myocytes. Single ventricular myocytes were first enzymatically isolated from WT and *Scn3b*^−/−^ hearts. To examine the localization of *β*~3~ subunits in these myocytes, an antibody specific to an epitope of the *β*~3~ protein was used and visualized using immunocytochemistry. These experiments confirmed the expression of *β*~3~ subunits of WT myocytes (*n* = 7 cells) in a striated pattern ([Fig. 2a](#fig02){ref-type="fig"}). In contrast, no such expression was shown in *Scn3b*^−/−^ myocytes (*n* = 8 cells, [Fig. 2b](#fig02){ref-type="fig"}).

![Immunostaining of *β*~3~ subunits in wild-type (WT) and *Scn3b*^−/−^ myocytes. A single cardiac myocyte isolated from a WT heart showing the expression of *β*~3~ subunits in a striated pattern (a: left panel). This expression is absent in *Scn3b*^−/−^ myocytes (b: left panel). The integrity of the cardiac myocytes is confirmed by the corresponding bright field images (a, b: right panels).](apha0198-0047-f2){#fig02}

Scn3b^*−/−*^ mice exhibit abnormal ECG characteristics
------------------------------------------------------

The subsequent electrophysiological studies obtained both ECGs from intact mice ([Fig. 3](#fig03){ref-type="fig"}) and BEG from isolated perfused hearts ([Figs 4--8](#fig08){ref-type="fig"}). The ECG recordings permitted detailed visualization of individual features relating to conduction through different regions of the heart. The BEG recordings permitted correlation of the timings of individual atrial and ventricular deflections. The initial electrophysiological experiments thus compared lead I ECGs from anaesthetized intact WT (*n* = 7) and *Scn3b*^−/−^ (*n* = 6) mice. [Figure 3a](#fig03){ref-type="fig"} shows a single ECG complex obtained from a WT mouse. This is displayed at a rapid time base to emphasize the relevant ECG features, in which an asterisk (\*) represents the P wave. It confirms previous studies, in which it was difficult to identify the QRS complex, as the early repolarization phase was distorted by the T wave ([@b3], [@b9], [@b6]). Nevertheless, values of the following features could be obtained from these recordings from the WT and *Scn3b*^−/−^ mice ([Table 1](#tbl1){ref-type="table"}): RR interval, P wave duration, PR, QT~peak~, QT, QTc~-peak~ and QTc interval. The latter two characteristics were corrected for the RR interval. These individual values were obtained over a 1-min period and averaged to minimize error due to beat to beat variations, giving mean ± SEM values.

![Surface ECGs from anaesthetized wild-type (WT) and *Scn3b*^−/−^ mice. (a) Single electrocardiographic PQRST complex obtained from a WT mouse. The asterisk (\*) represents the P wave. (b) Representative ECG recordings obtained from WT (top panel) and *Scn3b*^−/−^ mice (bottom panel). *Scn3b*^−/−^ mice (*n* = 5) consistently showed a slower heart rate and prolonged PR interval compared to those shown in WT mice (*n* = 7, *P* \< 0.001). (c) ECG from a *Scn3b*^−/−^ mouse that showed ventricular, QT complexes, that were independent of the atrial, P, waves. Despite the regular interval between the P waves, the intervals between the QT complexes were irregular. ECG traces are also shown at a faster time base (b and c: right panels).](apha0198-0047-f3){#fig03}

![Bipolar electrogram (BEG) traces recorded from spontaneously beating wild-type (WT) and *Scn3b*^−/−^ hearts. (a) Representative BEG recording from a spontaneously beating isolated, Langendorff-perfused WT murine cardiac preparation. Such preparations demonstrated closely coupled atrial (*a*) and ventricular (*v*) deflections reflecting a sinus rhythm. In all BEG recordings, the ventricular signals resulted in larger spikes than the smaller atrial spikes. (b) Representative traces of the abnormalities observed in isolated, Langendorff-perfused spontaneously beating *Scn3b*^−/−^ hearts. In contrast in the WT, all *Scn3b*^−/−^ heart preparations persistently demonstrated abnormal atrial and ventricular deflections, which were not synchronized with each other, suggesting third degree heart block.](apha0198-0047-f4){#fig04}

![Differences in the atrio-ventricular intervals between spontaneously beating wild-type (WT) and *Scn3b*^−/−^ hearts. (a) Representative bipolar electrogram (BEG) recording from a WT heart at a faster time base than shown in [Figure 4](#fig04){ref-type="fig"}. (b) Recording of an exceptional episode of sinus rhythm (SR) shown in *Scn3b*^−/−^ hearts. When compared with an SR consistently shown in WT (a), a significantly longer interval was observed between the atrial and ventricular deflection and is suggestive of first degree heart block. (c) Values of the atrial-ventricular (A-V) interval (mean ± SEM) in WT and *Scn3b*^−/−^ hearts (black and white columns respectively). Significance levels of *P* \< 0.001 (single factor [anova]{.smallcaps}) demonstrate differences between WT (*n* = 15 hearts) and *Scn3b*^−/−^ hearts (*n* = 4 hearts). In all cases, the ventricular spikes result in the larger, and the atrial spikes in the smaller deflections.](apha0198-0047-f5){#fig05}

![Electrogram abnormalities recorded from intrinsically paced *Scn3b*^−/−^ hearts. (a) Single dropped atrial deflections (\*) in bipolar electrogram (BEG) recordings from *Scn3b*^−/−^ hearts, against a background of irregular ventricular activity, occurring at intervals larger than those of the atrial deflections. (b) BEG recording demonstrating a spontaneous episode of atrial tachycardia (AT) showing a frequency of ∼20 Hz. This phenomenon was observed in two of the 15 hearts studied. In all cases, the ventricular spikes result in the larger (*v*), and the atrial spikes in the smaller deflections (*a*).](apha0198-0047-f6){#fig06}

![Results from atrial burst pacing (ABP) in wild-type (WT) (a, b) and *Scn3b*^−/−^ (c--h) Langendorff-perfused hearts. Trace exemplifying a persistence of sinus rhythm following ABP in WT preparations in slow (a) and fast (b) time bases. (c--h) Examples of persistently regular atrial rhythm (c, d), atrial tachycardia resulting in regular deflections at a higher frequency (e, f) and atrial fibrillation resulting in irregular deflections at a higher frequency (g, h). In all cases, the ventricular spikes result in the larger, and the atrial spikes in the smaller deflections.](apha0198-0047-f7){#fig07}

![Sinus node recovery time in wild-type (WT) and *Scn3b*^−/−^ hearts. Bipolar electrogram (BEG) recordings showing the sinus node recovery time (SNRT) in (a) WT and (b) *Scn3b*^−/−^ hearts. (c) Mean (±SEM) SNRT values measured from WT (*n* = 5 hearts) and *Scn3b*^−/−^ hearts (*n* = 5 hearts) (black and white columns respectively). Significance level of *P* \< 0.001 (single factor [anova]{.smallcaps}) demonstrates differences in the SNRT of WT and *Scn3b*^−/−^ hearts.](apha0198-0047-f8){#fig08}

###### 

ECG characteristics of wild-type and *Scn3b*^−/−^ mice

                         Wild-type (*n* = 7)   *Scn3b*^−/−^ (*n* = 5)
  ---------------------- --------------------- -----------------------------------------------------------------------------
  RR (ms)                176 ± 1               250 ± 1[\*](#tf1-1){ref-type="table-fn"}
  P wave duration (ms)   9.5 ± 0.1             10.6 ± 0.2[\*](#tf1-1){ref-type="table-fn"}[†](#tf1-2){ref-type="table-fn"}
  PR (ms)                38 ± 0.1              42.2 ± 0.3[\*](#tf1-1){ref-type="table-fn"}
  QT~peak~ (ms)          29.2 ± 0.3            30.7 ± 1
  QT (ms)                54.8 ± 0.7            55.8 ± 0.5
  QTc~-peak~ (ms)        22.7 ± 0.3            22.6 ± 1.2
  QTc (ms)               41.5 ± 0.5            40.6 ± 0.6

*P* \< 0.001.

Calculated from six mice.

[Figure 3b](#fig03){ref-type="fig"} shows ECG traces of WT (top panel) and *Scn3b*^−/−^ (bottom panel) mice demonstrating sinus rhythm (SR). This figure also shows these traces at a faster time base (right panels) to allow identification of specific ECG features. Thus, every WT mouse studied showed SR with an RR interval of 176 ± 1 ms (*n* = 7). This RR interval corresponded to an HR of 392 ± 2 beats min^−1^. Five of the six *Scn3b*^−/−^ mice showed SR. However, they showed a significantly longer RR interval of 250 ± 1 ms (*n* = 5) compared to that shown by WT mice (*P* \< 0.001). This corresponded to a slower HR of 356 ± 8 beats min^−1^ ([Fig. 3b](#fig03){ref-type="fig"}, bottom panel). The remaining *Scn3b*^−/−^ mouse showed P waves occurring at regular intervals and QRS complexes occurring independently at irregular intervals throughout the 5 min recording period ([Fig. 3c](#fig03){ref-type="fig"}). Closer inspection of the trace at a faster time base (right panel) demonstrates that the ECG waveforms were similar to those shown previously ([Fig. 3a,b](#fig03){ref-type="fig"}, right panels). A second *Scn3b*^−/−^ mouse that showed SR initially for 3 min also showed the abnormal characteristics described above. The P waves shown in *Scn3b*^−/−^ mice were similar to those shown in WT mice ([Fig. 3b](#fig03){ref-type="fig"}). However, the P wave duration in the *Scn3b*^−/−^ mice was 10.6 ± 0.2 ms (*n* = 6), which was significantly longer than that observed in WT mice (9.5 ± 0.1 ms, *n* = 7; *P* \< 0.001). The five *Scn3b*^−/−^ mice that exhibited SR also showed a longer PR interval (42.2 ± 0.3 ms, *n* = 5) than that shown by WT mice (38 ± 0.1 ms, *n* = 7; *P* \< 0.001). The QT~peak~, QT, QTc~-peak~ and QTc values were similar in WT and *Scn3b*^−/−^ mice ([Table 1](#tbl1){ref-type="table"}).

Scn3b^*−/−*^ hearts exhibit abnormal spontaneous atrial activity
----------------------------------------------------------------

Experiments in isolated Langendorff-perfused WT and *Scn3b*^−/−^ hearts first examined spontaneously beating hearts. These involved BEG recordings that permitted the timings of atrial, and the larger ventricular deflections to be compared. This assessment permitted detection both of different degrees of heart block, as well as abnormal patterns of atrial activity. [Figure 4a](#fig04){ref-type="fig"} shows both atrial (*a*) and ventricular (*v*) deflections in a representative BEG recording obtained from a WT heart. These hearts showed a mean basic cycle length (BCL) of 168 ± 6.8 ms (*n* = 15 hearts). The recordings obtained from all 15 WT hearts consistently demonstrated SR, characterized by regular and closely coupled atrial and ventricular deflections at a constant A-V interval.

In contrast to the observations in WT mice and the ECG findings in intact *Scn3b*^−/−^ mice, all the *Scn3b*^−/−^ hearts showed abnormal atrial activity in a pattern that was not gender specific ([Table 2](#tbl2){ref-type="table"}). Firstly, *Scn3b*^−/−^ hearts showed evidence of A-V heart block. Thus, the BEG recordings from all 15 *Scn3b*^−/−^ hearts studied largely consisted of successive atrial deflections which were irregularly timed ([Fig. 4b](#fig04){ref-type="fig"}). Furthermore, the ventricular deflections occurred asynchronously and at irregular intervals, giving a pattern resembling third degree heart block. Accordingly, the usual pattern of SR seen in WT hearts was the exception, rather than the rule. Thus, the BEG recordings demonstrated 12 episodes of SR in only 4 of 15 *Scn3b*^−/−^ hearts. Each episode lasted a mean duration of 237.3 ± 85.2 s. These *Scn3b*^−/−^ hearts then showed a BCL of 159 ± 3.8 ms that was not significantly different from the BCL shown in the SR of WT hearts (*P* \> 0.05). These episodes of SR were accompanied by a significantly increased A-V interval compared to that shown in WT hearts. Thus, the A-V interval of the 15 WT hearts studied was 29.5 ± 0.28 ms ([Fig. 5a](#fig05){ref-type="fig"}), whereas the A-V interval measured in the *Scn3b*^*−/−*^ hearts during such episodes of an SR was 52.5 ± 0.59 ms (4 of 15 hearts, *P* \< 0.001) ([Fig. 5b,c](#fig05){ref-type="fig"}). These findings are consistent with A-V conduction delay and first degree heart block.

###### 

Atrial electrogram abnormalities observed in spontaneously beating *Scn3b*^−/−^ hearts

                Electrogram features in *Scn3b*^−/−^ hearts              
  ---- -------- --------------------------------------------- ------ --- -----
  1    Female   ✓                                                    ✓   
  2    Female   ✓                                                    ✓   
  3    Female   ✓                                             Four   ✓   Six
  4    Male     ✓                                                    ✓   
  5    Male     ✓                                                        
  6    Male     ✓                                                    ✓   
  7    Female   ✓                                             Two    ✓   
  8    Female   ✓                                             Five   ✓   
  9    Female   ✓                                                    ✓   
  10   Female   ✓                                                        
  11   Male     ✓                                                    ✓   
  12   Male     ✓                                                    ✓   Two
  13   Male     ✓                                                    ✓   
  14   Female   ✓                                             One    ✓   
  15   Female   ✓                                                    ✓   

SR, sinus rhythm; AT, atrial tachycardia.

Total of 12 episodes with a mean duration of 237.3 ± 85.2 s (*n* = 4). All episodes were accompanied by a prolonged atrial-ventricular interval.

Total of eight episodes with a mean duration of 2.37 ± 0.7 ms (*n* = 2).

Secondly, even during such episodes of atrial deflections occurring at a normal BCL, there were missing atrial deflections in the BEG recordings (marked with an asterisk, [Fig. 6a](#fig06){ref-type="fig"}) observed in 13 of the 15 *Scn3b*^−/−^ hearts studied. This phenomenon is suggestive of sinus node exit block. Thirdly, a total of eight episodes of spontaneous atrial tachycardia (AT) ([Fig. 6b](#fig06){ref-type="fig"}) occurred in 2 of the 15 *Scn3b*^−/−^ hearts. Each episode had a mean duration of 2.37 ± 0.7 s. The average BCL of each episode at 44 ± 1.9 ms was significantly decreased (*P* \< 0.001) from the BCL normally observed in atrial deflections (marked *a*) in hearts showing SR. Fourthly, BEG recordings of all 15 *Scn3b*^−/−^ hearts demonstrated episodes of irregularly timed ventricular deflections (marked *v*), even during periods of regular atrial deflections that took place at a normal BCL. In the BEG recording shown in [Figure 6a](#fig06){ref-type="fig"}, the intervals separating the ventricular deflections were up to five to seven times longer than those separating the atrial deflections. Finally, none of the *Scn3b*^−/−^ hearts studied showed spontaneous AF. The above findings nevertheless suggest significant abnormalities in both atrial activity and conduction between the atria and ventricles in spontaneously beating *Scn3b*^−/−^ hearts.

Atrial burst pacing induces atrial arrhythmogenesis in Scn3b^−/−^ hearts
------------------------------------------------------------------------

The effects of electrical stimulation were then used to investigate the inducibility of atrial arrhythmias and sinus dysfunction. These experiments used stimulating electrodes positioned on the RA appendages in the same hearts as described above. The ABP experiments applied single drive trains each consisting of 50 stimuli at a CL of 20 ms, when the hearts were in periods of spontaneous and regular atrial activity. [Figure 7](#fig07){ref-type="fig"} illustrates BEG recordings obtained before, during and immediately after the application of the ABP protocols, indicated by the closely spaced large deflections immediately above the 1 s time bar. The 15 WT hearts were subjected to a total of 622 ABP protocols, corresponding to an average of 41.5 ± 2.6 ABP protocols in each heart. All 15 hearts remained in SR following 99.2 ± 0.4% of the applied ABP protocols (617 out of a total of 622 protocols) ([Fig. 7a](#fig07){ref-type="fig"}). Closer inspection of the BEG recordings at a faster time base then demonstrated regular and consistent A-V intervals, with each of the successive atrial and ventricular deflections identical in waveform ([Fig. 7b](#fig07){ref-type="fig"}). The remaining 0.8 ± 0.4% of the applied ABP protocols (5 of the 622 protocols) induced episodes of AT. This occurred in only 4 of 15 hearts. Each episode lasted a mean duration of 1.2 ± 0.2 s. None of the 15 WT hearts studied demonstrated episodes of AF despite the application of 622 ABP protocols.

In contrast to WT hearts, all 13 *Scn3b*^−/−^ hearts that were subject to ABP demonstrated significant subsequent atrial arrhythmogenicity. The further two hearts demonstrated spontaneous episodes of AT (hearts 3 and 12, [Table 2](#tbl2){ref-type="table"}) and were not studied using ABP. The *Scn3b*^−/−^ hearts were subject to a total of 645 ABP protocols, corresponding to 49.6 ± 6.1 ABP protocols in each heart. Firstly, following the application of 51.2 ± 6.0% of the ABP protocols performed in all the hearts (308 out of the total of 645 protocols), the *Scn3b*^−/−^ hearts continued to show a pattern of electrogram deflections similar to those shown prior to the application of the protocols ([Fig. 7c](#fig07){ref-type="fig"}). When displayed at a faster time base ([Fig. 7d](#fig07){ref-type="fig"}), the individual atrial deflections in such cases were similar in waveform to those shown in BEG recordings of WT hearts ([Fig. 7b](#fig07){ref-type="fig"}). Secondly, 24.7 ± 3.8% of the applied ABP protocols (169 of the total of 645 protocols) produced episodes of AT, with a mean duration of 6.92 ± 1.83 s for each episode. This phenomenon was seen in all 13 *Scn3b*^−/−^ hearts. [Figure 7e](#fig07){ref-type="fig"} illustrates a BEG recording of such an episode of induced AT. Again, display of such records at a faster time base showed successive atrial deflections with similar waveforms and amplitudes ([Fig. 7f](#fig07){ref-type="fig"}). However, these occurred at a significantly shorter BCL compared to that of atrial deflections displaying SR. Finally, the remaining 24.1 ± 4.6% of all the performed ABP protocols (168 out of the 645 protocols) induced episodes of AF ([Fig. 7g](#fig07){ref-type="fig"}). Each episode lasted a mean duration of 10.7 ± 2.9 s. This was observed in all the 13 *Scn3b*^−/−^ hearts. The atrial activity in these episodes was irregular, with successive atrial deflections assuming different amplitudes ([Fig. 7h](#fig07){ref-type="fig"}). This was in contrast to the regular atrial deflections shown in AT ([Fig. 7f](#fig07){ref-type="fig"}) or SR ([Fig. 7b](#fig07){ref-type="fig"}).

Scn3b^−/−^ hearts demonstrate sinus node dysfunction
----------------------------------------------------

Sino-atrial conduction was assessed by analysing the SNRT in the whole heart preparations. A total of 18 such procedures were applied to each of the WT ([Fig. 8a](#fig08){ref-type="fig"}) and *Scn3b*^−/−^ hearts ([Fig. 8b](#fig08){ref-type="fig"}) (*n* = 5 hearts each). The *Scn3b*^−/−^ hearts demonstrated a significantly longer SNRT (529 ± 28.8 ms) than that of the WT hearts (221 ± 9.7 ms, *P* \< 0.001) ([Fig. 8c](#fig08){ref-type="fig"}).

Taken together, the above findings clearly demonstrate readily inducible atrial arrhythmias and significant conduction abnormalities in *Scn3b*^−/−^ hearts, in contrast to WT hearts.

Discussion
==========

Alterations in the pore-forming *α*-subunits of the cardiac sodium (Na^+^) channel have previously been associated with cardiac arrhythmic conditions including BrS and LQTS ([@b4], [@b33]). However, mammalian Na^+^ channels also include one or more *β*-subunits whose specific associations with *α*-subunits have yet to be fully characterized. Nevertheless, analysis of the protein structures has suggested that on the one hand, *β*~1~ and *β*~3~ subunits can be non-covalently associated with *α*-subunits ([@b15], [@b28]). On the other hand, *β*~2~ and *β*~4~ subunits may associate with *α*-subunits through covalent bonds ([@b16], [@b37]). Furthermore, immunofluorescence studies have demonstrated that the *β*~1~ and *β*~3~ subunits are expressed along with the neuronal Na~v~1.1, Na~v~1.3 and Na~v~1.6 *α*-subunits in the transverse-tubules of mouse ventricular myocytes. In contrast, Na~v~1.5 *α*-subunits were expressed in the intercalated discs along with the remaining *β*~2~ and *β*~4~ subunits ([@b22]). All four *β*-subunits are also expressed in the mouse sinus node ([@b21]).

*β*-subunits have been shown to regulate the level of Na^+^ channel expression in the plasma membrane ([@b17]) and may also have roles similar to those of CAMs ([@b14]). In addition, mutations in or the absence of *β*-subunits have been associated with alterations in the gating kinetics of the Na^+^ channel. Such effects were demonstrated in whole cell patch-clamp studies in mouse ventricular myocytes ([@b20], [@b11]), human embryonic kidney (HEK293) cells ([@b26]), Chinese hamster ovary (CHO) cells ([@b34]) and *Xenopus* oocytes ([@b24]). Similar results were also obtained from two-electrode voltage clamp studies in *Xenopus* oocytes ([@b28]) and CHO cells ([@b18]).

However, only three clinical studies have thus far related alterations in *β*-subunits to ventricular arrhythmogenesis. Thus, mutations in the *SCN4B* gene resulting in altered *β*~4~ subunits were linked to LQTS ([@b26]). These mutations appeared to alter the gating properties of the Na^+^ channel in HEK293 cells expressing both the Na~v~1.5 and the altered form of the *β*~4~ subunit ([@b26]). Such co-expression resulted in larger late Na^+^ window currents than shown by cells expressing WT *β*~4~ and Na~v~1.5 subunits. This could account for the LQTS-like clinical features ([@b2], [@b1]). Mutations in the *SCN1B* and *SCN3B* genes, resulting in altered *β*~1~ and *β*~3~ subunits, respectively, were associated with human BrS ([@b34], [@b13]). CHO cells transfected with WT-*SCN5A* and the mutated *SCN1B* gene showed significant decreases in the size of the Na^+^ current ([@b34]). Transfection of the mutated form of the *SCN3B* gene with WT *SCN5A* and *SCN1B* genes appeared to prevent the localization of the Na^+^ channel to the surface membrane in modified human embryonic kidney cells, TSA201 ([@b13]). This also resulted in a significantly reduced Na^+^ current compared to that shown in cells transfected with WT *SCN5A*, *SCN1B* and *SCN3B* genes.

Similarly, there has only been one report associating modifications of *β*-subunits with clinical changes in atrial electrophysiology. Thus, in 480 patients with AF, two mutations in the *SCN1B* gene and two mutations in the *SCN2B* gene were identified ([@b35]). Each mutation occurred separately in four AF patients. Transfection of the Na~v~1.5 subunit with either of the mutated *β*~1~ or *β*~2~ subunits in CHO cells demonstrated reduced Na^+^ currents when compared with currents shown in cells transfected with WT Na~v~1.5 subunit and *β*-subunits.

The present experiments demonstrate, for the first time, an atrial arrhythmic and conduction phenotype in a genetically modified murine model deficient in the *β*~3~ subunit of the Na^+^ channel. A previous report had described the generation of the *Scn3b*^−/−^ mice, using homologous recombination in embryonic stem cells ([@b11]). Firstly, RT-PCR experiments demonstrated a significant expression of *Scn3b* mRNA in both the RA and LA appendages of WT, but not of *Scn3b*^−/−^ hearts. In contrast, the expression levels of *Scn5a* and *Scn1b* mRNA were similar in both WT and *Scn3b*^−/−^ hearts, despite the 57% identity between the *Scn1b* and *Scn3b* genes ([@b28]). Furthermore, ratios between the *β*~3~ and Na~v~1.5 mRNA expression levels in the LA and RA appendages of WT murine hearts were 1 : 470 and 1 : 380 respectively. The overall ratio in the atria of WT murine hearts was thus 1 : 420. This larger mRNA expression level of *α*-subunits than *β*-subunits confirms an earlier report, which examined the mRNA expression levels of ion channel subunits, including *β*~1~, *β*~3~ and Na~v~1.5 subunits in WT murine hearts ([@b25]). However, [@b25] reported a smaller ratio of 1 : 200 between the *β*~3~ and Na~v~1.5 mRNA expression levels, suggesting a larger *β*~3~ mRNA expression level in WT atrial tissue.

Secondly, immunofluorescence experiments confirmed the expression, or otherwise, of the *β*~3~ subunit in the WT and *Scn3b*^−/−^ myocytes respectively. These experiments applied an antibody specific to the *β*~3~ protein to isolated cardiac myocytes from WT and *Scn3b*^−/−^ mice. Confocal microscopic visualization then demonstrated that the *β*~3~ subunit was expressed in a striated pattern in WT myocytes. This confirms a previous study which showed a similar expression pattern of *β*~3~ subunits in WT myocytes ([@b22]). In contrast, no such expression was observed in *Scn3b*^−/−^ myocytes. The above findings confirm the results of the expression studies of *Scn3b* mRNA.

Thirdly, the surface ECG findings show, for the first time, conduction abnormalities in the atria and ventricles of anaesthetized *Scn3b*^−/−^ mice. On the one hand, all seven WT mice demonstrated SR. They showed an RR interval corresponding to an HR of 392 ± 2 beats min^−1^. This is lower than the HR observed in conscious WT mice, which typically ranges from 450 to 750 beats min^−1^. However, this observation is consistent with the lower HR demonstrated in mice anaesthetized with ketamine and xylazine ([@b6], [@b36]). On the other hand, five of the six *Scn3b*^−/−^ mice also showed SR. Under the same anaesthetic conditions, these mice showed a slower HR of 356 ± 8 beats min^−1^. This is consistent with a previous finding in *Scn1b*^−/−^ hearts ([@b20]). *Scn3b*^−/−^ mice also showed longer P wave durations and more prolonged PR intervals compared to those shown in WT mice, suggesting conduction abnormalities. These findings are similar to a previous clinical report, which associated alterations in the *β*~1~ subunit with conduction abnormalities. Thus, patients with mutations in the *SCN1B* gene demonstrated prolonged PR and His-ventricular intervals ([@b34]). Two *Scn3b*^−/−^ mice showed abnormal ventricular rhythms, with one mouse showing abnormalities throughout the 5 min recording period and the second mouse showing such abnormalities after an initial 3 min period of SR.

Fourthly, e*x vivo* experiments in isolated Langendorff-perfused hearts demonstrated marked abnormalities in the electrophysiology of *Scn3b*^−/−^ hearts. They directly recorded BEGs from the LA appendages of spontaneously beating WT and *Scn3b*^−/−^ hearts. WT hearts then demonstrated SR, which consisted of regular and closely coupled atrial and ventricular deflections. In contrast, *Scn3b*^−/−^ hearts showed first and third degree heart block. They also showed dropped atrial deflections, consistent with sinus node exit block. Perfused hearts were then subjected to an ABP protocol, to assess provoked atrial arrhythmogenesis. WT hearts persistently showed SR following the application of the protocol. In contrast, *Scn3b*^−/−^ hearts demonstrated AT and fibrillation in response to the protocol. Finally, SNRT was measured to assess the function of the sinus node, which maintains the normal SR. The *Scn3b*^−/−^ hearts demonstrated a significantly longer SNRT compared to that shown in WT hearts.

In summary, we provide empirical evidence that normal expression of Na^+^ channel *β*~3~ subunits is important in atrial function and conduction between the atria and ventricles. Thus, both *ex vivo* and *in vivo Scn3b*^−/−^ preparations agreed in showing evidence of heart block and conduction abnormalities. This phenotype was significantly more marked in the *ex vivo* hearts. These findings at the whole heart level might now be followed by further investigations at the cellular level possibly for direct interactions of *β*~3~ with either tetrodotoxin (TTX)-resistant Na~v~1.5 or TTX-sensitive *α*-subunit isoforms.
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